Announcements Trials
Browse Landscape

Phase

Phase 3 2

Status

Unknown 1Completed 1

Sponsor Class

OTHER 2INDUSTRY 1

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 2

Conditions

Venous Thromboembolism 6Venous Thrombosis 5Pulmonary Embolism 5Neoplasms 5Thromboembolism 2Lung Neoplasms 2Thrombosis 1Thrombocytopenia 1Pancreatic Neoplasms 1Multiple Myeloma 1Lymphoma 1Liver Neoplasms 1Hemorrhage 1Colorectal Neoplasms 1Colonic Neoplasms 1Carcinoma, Ovarian Epithelial 1Carcinoma, Non-Small-Cell Lung 1Brain Neoplasms 1

Interventions

Enoxaparin 3Tinzaparin 2Saline Solution 2Heparin, Low-Molecular-Weight 2Heparin 2Gemcitabine 2Fondaparinux 2Dalteparin 2130-nm albumin-bound paclitaxel 2palbociclib 1enoxaparin sodium 1edoxaban 1apixaban 1Warfarin 1Tranexamic Acid 1Sodium Chloride 1Sodium Bicarbonate 1Rivaroxaban 1Pentetic Acid 1PEGPH20 1Minocycline 1Ketoconazole 1Fluorodeoxyglucose F18 1Fluoridation 1Estramustine 1Enzyme-Linked Immunosorbent Assay 1Doxorubicin 1Docetaxel 1Aspirin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
OTHER × Thromboembolism × Tinzaparin × Clear all
NCT05625932 2025-08-22

PROTINCOL

Galician Research Group on Digestive Tumors

Phase 3 Completed
232 enrolled
Gastrointestinal

Thromboembolism, Colorectal Neoplasms

NCT05178628 2022-03-29

imPaCT-PRO

Institute of Molecular Medicine and Biomedical Research

Phase 3 Unknown
450 enrolled
Gastrointestinal

Pancreatic Neoplasms, Thromboembolism

Data powered by HemOnc (CC BY 4.0) Colophon âš¡